AWM
RVMD icon

Abound Wealth Management’s Revolution Medicines RVMD Stock Holding History

Abound Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$375 Buy
+2
New +$292 ﹤0.01% 998

Other funds holding RVMD

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
SCA
Sandy Cove Advisors Hingham, Massachusetts $400M AUM 27.68% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Abound Wealth Management's RVMD Position: Q2 2026 in Review

Abound Wealth Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 2 shares worth $375. The stake represents ﹤0.01% of the portfolio and ranks #998 among its holdings.

82 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Abound Wealth Management held 2 shares of Revolution Medicines worth $375 as of Q2 2026.
  • Revolution Medicines was a new Abound Wealth Management position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #998 holding.
  • 82 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.